Who should ask about kidney testing?

CDC identifies diabetes, high blood pressure, heart disease, and family history among important kidney-disease risks. Feeling well does not settle whether testing would be useful: early kidney disease may not cause symptoms.

If one of these risks applies, ask where kidney testing fits into your care. This is not a recommendation that every adult needs the same tests on the same schedule. Bring your history and previous laboratory reports so the clinician can decide what is appropriate. Our blood-pressure screening guide addresses a related but different part of preventive care.

What does an eGFR result describe?

As NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) explains, creatinine is a waste product from muscle activity that kidneys remove from the blood. A blood creatinine measurement is used to estimate the glomerular filtration rate, or eGFR. The estimate describes kidney filtering function.

Ask the clinician to explain the actual report rather than comparing your number with a relative's. Useful questions include: “Is this different from my previous result?” and “Does anything else in my history change how you interpret it?” Save the date, result, and clinician's explanation together so future comparisons have context.

What does a urine albumin test add?

CDC's testing guide explains that urine testing can look for protein leakage. A urine albumin-to-creatinine ratio, or UACR, compares the albumin and creatinine in a urine sample. It is different from a general urine dipstick, which does not provide the same exact albumin measurement.

If you see “urinalysis” in a portal, ask which measurements were actually included. Likewise, do not assume that a blood panel includes a urine test. You do not need to order your own test bundle: ask the clinician to identify the information needed for your situation.

A flagged result is a reason for a plan, not self-diagnosis

Both CDC and NIDDK describe repeat urine testing as a possible step to confirm an abnormal albumin result. Ask whether your result needs repeating, other testing, or an appointment, and how quickly that should happen. Your clinician must interpret the findings rather than a portal flag doing that work.

Keep two questions separate: “What does this result suggest?” and “What happens next?” Even if an explanation is still being worked out, you should know who will contact you, when a repeat sample is due, and which concerns should prompt earlier contact. If the office gives urgent instructions, follow them rather than waiting for a routine visit.

How often should tests be repeated?

NIDDK advises yearly kidney checks for people with diabetes and a discussion about frequency for those with high blood pressure, heart disease, or a family history of kidney failure. An individual monitoring plan may differ according to previous results and clinical needs. Confirm your own interval instead of copying someone else's reminder schedule.

Before leaving a visit, write down the next test or review date and whether a laboratory order has already been placed. If different clinicians are involved, ask which office is coordinating the kidney follow-up. This can reduce uncertainty about who is expected to review a result.

Prepare for the laboratory visit without guessing

Ask the ordering office or laboratory for preparation and collection instructions for the tests actually ordered. Confirm whether other tests on the same order affect preparation, where to go, whether an appointment is required, and how results will reach the clinician.

Bring a current medicine and supplement list, along with any recent outside results. Do not independently stop prescriptions, change doses, start a “kidney cleanse,” or make major diet or fluid changes in response to a portal result. Discuss questions with the appropriate clinician or pharmacist. The goal is an accurate review, not changing your routine to try to produce a particular number.

Six questions for a focused kidney-health conversation

  1. Does my health or family history make testing appropriate?
  2. Which blood and urine measurements do I need, and why?
  3. How do these results compare with my own previous tests?
  4. Is confirmation or additional evaluation needed?
  5. Who will explain the results, and by what date should I follow up if I have not heard?
  6. What are the separate visit and laboratory costs under my insurance or self-pay arrangement?

A virtual visit can support discussion of history and available reports, but it cannot collect a blood or urine sample. Confirm the appropriate laboratory arrangement and whether an in-person examination is also needed. See our visit-format guide and self-pay questions for practical planning.

Frequently asked questions

What are the main tests used to check kidney health?

A blood test helps estimate filtration, reported as eGFR, while urine testing can check for albumin, often using a urine albumin-to-creatinine ratio (UACR). They provide different information and should be interpreted with your history and other findings.

Should I ask about kidney testing if I feel well?

Yes, if you have risk factors such as diabetes, high blood pressure, heart disease, or a family history of kidney disease. Early kidney disease may have no symptoms. Ask your clinician whether testing is appropriate and how often to repeat it.

Does one abnormal kidney test prove I have chronic kidney disease?

Do not diagnose yourself from a flagged result. Ask your clinician what it means in context, whether confirmation or other evaluation is needed, and how soon to follow up. A repeat test may be part of the plan.

Can a telehealth visit perform a kidney blood or urine test?

No. A virtual appointment can support a discussion of history and available results, but samples must be collected through an appropriate in-person laboratory or other approved arrangement. Confirm orders, collection instructions, costs, and follow-up with the clinic.

Authoritative sources

Sources checked October 19, 2026. CDC's testing and risk pages are dated May 2024; NIDDK's patient page was last reviewed October 2016. The check date is not a new guideline publication date.